Facebook Linkedin Tumblr Twitter
Sign in
  • My Account
  • orders
Sign in
Welcome!Log into your account
Forgot your password?
Password recovery
Recover your password
Search
  • Sign in / Join
Facebook Linkedin Tumblr Twitter
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.
Market Exclusive #1 Financial News & Analysis Market Exclusive
Market Exclusive #1 Financial News & Analysis
  • My Account
  • orders
Home Biotech Stocks

Biotech Stocks

Random
  • Latest
  • Featured posts
  • Most popular
  • 7 days popular
  • By review score
  • Random
Teva Pharmaceutical Industries Ltd

Here’s What’s Moving Teva Pharmaceutical Industries And Madrigal Pharmaceuticals

- February 9, 2018

Here’s What The Latest Data Could Mean For Repros Therapeutics Inc (NASDAQ:RPRX)

AstraZeneca plc (ADR) (NYSE:AZN) Reports Positive Results In Phase 3 Study Of Bevespi

bacteria

Biotech Movers: Reata Pharmaceuticals, Inc. (NASDAQ:RETA) and Savara Inc. (NASDAQ: SVRA)

Mylan NV

Mylan N.V. (NASDAQ:MYL) Given Go-Ahead For Angiomax In Blow To Medicines Company (NASDAQ:MDCO)

biotech report

Weekly Biotech Report Covering Epizyme Inc (NASDAQ:EPZM)

David Rich - June 20, 2016 0

Can Valeant Pharmaceuticals Intl Inc (NYSE:VRX) Hit Three For Three Tomorrow?

- July 20, 2016 0
Medtronic Plc

Medtronic plc. (NYSE:MDT) Opens First Canadian Medtronic Resource Centre To Serve...

Andy Parker - June 15, 2017 0
A sign is seen at an AstraZeneca site in Macclesfield

AstraZeneca plc (ADR)(NYSE:AZN) Participates In ADC Therapeutics’ $200 Million Funding Round

- October 24, 2017 0
stocks

Here’s What’s Moving Galena Biopharma, Inc. (NASDAQ:GALE) and Progenics Pharmaceuticals, Inc....

- January 2, 2018 0

Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) Is Running On Some Early Stage Data

ME Staff - April 11, 2018 0
Amgen, Inc

FDA Approves Amgen, Inc. (NASDAQ:AMGN) Drug For Treating Secondary Hyperparathyroidism

Andy Parker - February 8, 2017 0

Biotech Movers: PTC Therapeutics, Inc. (NASDAQ:PTCT) and Alkermes plc (NASDAQ:ALKS).

- June 7, 2017 0
Clovis

Clovis up on Ovarian Cancer, Lung Cancer Reports

ME Staff - June 1, 2015 0

Here’s What Just Happened With Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) and Aeterna...

- July 21, 2017 0
123...146Page 1 of 146

Latest Articles

  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector
  • Weekly Roundup on the Cannabis Sector & Psychedelic Sector

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 13, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

April 6, 2026

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

March 29, 2026

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016
biotechnology

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

POPULAR CATEGORY

  • SEC Filings97015
  • Analyst Ratings21747
  • Insider Trading7769
  • Earnings4727
  • LSE4165
  • dividend announcements2433
  • Tech News1583
  • Stocks1511
  • Stock Market News1478
Market Exclusive #1 Financial News & Analysis
ABOUT US
Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.
Contact us: [email protected]
FOLLOW US
Facebook Linkedin Tumblr Twitter
  • SEC Filings
  • Stocks
  • Stock Market News
  • Tech News
  • Biotech Stocks
  • Featured
  • Small Caps
  • gold
  • Other News
  • Oil
  • Become a Contributor!
  • Advertise On Market Exclusive
  • Contact Us
© Market Exclusive 2019